Necroptosis: Mechanisms and Relevance to Disease

Annual Review of Pathology: Mechanisms of Disease

Volumn 12, Issue , 2017, Pages 103-130

  Galluzzi, Lorenzo ^a,b,c,d,e,f   Kepp, Oliver ^b,c,d,e,f   Chan, Francis Ka Ming ^g   Kroemer, Guido ^{b,c,d,e,f,h,i}  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Caspases; Damage associated molecular patterns; Immunogenic cell death; Inflammation; Mitochondrial permeability transition; Necrostatin 1

Indexed keywords

REGULATOR PROTEIN; UNCLASSIFIED DRUG; UPSTREAM REGULATOR PROTEIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN;

APOPTOSIS; CARDIOVASCULAR DISEASE; CELL DEATH; DISEASE ASSOCIATION; HUMAN; INFECTION; INFLAMMATORY DISEASE; INTRACELLULAR SIGNALING; KIDNEY DISEASE; LIVER DISEASE; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; NECROPTOSIS; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASES; METABOLISM; NECROSIS;

ANIMALS; APOPTOSIS; DISEASE; HUMANS; NECROSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 85011258194     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-052016-100247     Document Type: Review

References (199)

1. Galluzzi L, Bravo-Pedro JM, Vitale I, Aaronson SA, Abrams JM, et al. 2015. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 22:58-73
2. Galluzzi L, Bravo-Pedro JM, Kroemer G. 2014. Organelle-specific initiation of cell death. Nat. Cell Biol. 16:728-36
3. Green DR, Galluzzi L, Kroemer G. 2014. Cell biology. Metabolic control of cell death. Science 345:1250256
4. Fuchs Y, Steller H. 2011. Programmed cell death in animal development and disease. Cell 147:742-58
5. Sica V, Galluzzi L, Bravo-Pedro JM, Izzo V, Maiuri MC, Kroemer G. 2015. Organelle-specific initiation of autophagy. Mol. Cell 59:522-39
6. Galluzzi L, Pietrocola F, Levine B, KroemerG. 2014. Metabolic control of autophagy. Cell 159:1263-76
7. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. 2014. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev.Mol. Cell. Biol. 15:135-47
8. Conrad M, Angeli JP, Vandenabeele P, Stockwell BR. 2016. Regulated necrosis: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 15:348-66
9. Sun L,Wang H,Wang Z, He S, Chen S, et al. 2012. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213-27
10. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, et al. 2012. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. PNAS 109:5322-27
11. Rodriguez DA, Weinlich R, Brown S, Guy C, Fitzgerald P, et al. 2016. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ. 23:76-88
12. Wu J, Huang Z, Ren J, Zhang Z, He P, et al. 2013. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23:994-1006
13. Remijsen Q, Goossens V, Grootjans S, Van den Haute C, Vanlangenakker N, et al. 2014. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinasedependent apoptosis. Cell Death Dis. 5:e1004
14. Tanzer MC, Tripaydonis A, Webb AI, Young SN, Varghese LN, et al. 2015. Necroptosis signalling is tuned by phosphorylation ofMLKL residues outside the pseudokinase domain activation loop. Biochem. J. 471:255-65
15. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, et al. 2013. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39:443-53
16. Cai Z, Jitkaew S,Zhao J,ChiangHC, Choksi S, et al. 2014. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16:55-65
17. Chen X, Li W, Ren J,Huang D, He WT, et al. 2014. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 24:105-21
18. Wang H, Sun L, Su L, Rizo J, Liu L, et al. 2014. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54:133-46
19. Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, et al. 2014. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. PNAS 111:15072-77
20. Quarato G, Guy CS, Grace CR, Llambi F, Nourse A, et al. 2016. Sequential engagement of distinct MLKL phosphatidylinositol-binding sites executes necroptosis. Mol. Cell 61:589-601
21. Dondelinger Y, DeclercqW, Montessuit S, Roelandt R, Goncalves A, et al. 2014. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 7:971-81
22. Jacobsen AV, Lowes KN, TanzerMC, Lucet IS, Hildebrand JM, et al. 2016. HSP90 activity is required forMLKL oligomerisation and membrane translocation and the induction of necroptotic cell death. Cell Death Dis. 7:e2051
23. Zhao XM, Chen Z, Zhao JB, Zhang PP, Pu YF, et al. 2016. Hsp90 modulates the stability of MLKL and is required for TNF-induced necroptosis. Cell Death Dis. 7:e2089
24. Bigenzahn JW, Fauster A, RebsamenM, Kandasamy RK, Scorzoni S, et al. 2016. An inducible retroviral expression system for tandem affinity purification mass-spectrometry-based proteomics identifies mixed lineage kinase domain-like protein (MLKL) as an heat shock protein 90 (HSP90) client. Mol. Cell. Proteom. 15:1139-50
25. Wang Z, Jiang H, Chen S, Du F,Wang X. 2012. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148:228-43
26. MoujalledDM, CookWD,Murphy JM, Vaux DL. 2014. Necroptosis induced by RIPK3 requiresMLKL but not Drp1. Cell Death Dis. 5:e1086
27. Tait SW, Oberst A, Quarato G, Milasta S, Haller M, et al. 2013. Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell Rep. 5:878-85
28. Moriwaki K, Farias Luz N, Balaji S, De Rosa MJ, O'Donnell CL, et al. 2016. The mitochondrial phosphatase PGAM5 is dispensable for necroptosis but promotes inflammasome activation in macrophages. J. Immunol. 196:407-15
29. Lu W, Sun J, Yoon JS, Zhang Y, Zheng L, Murphy E, Mattson MP, Lenardo MJ. 2016. Mitochondrial protein PGAM5 regulates mitophagic protection against cell necroptosis. PLOS ONE 11:e0147792
30. Galluzzi L, Kepp O, Kroemer G. 2012. Mitochondria: master regulators of danger signalling. Nat. Rev. Mol. Cell. Biol. 13:780-88
31. Newton K, Dugger DL, Wickliffe KE, Kapoor N, de AlmagroMC, et al. 2014. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343:1357-60
32. He S, Wang L, Miao L, Wang T, Du F, et al. 2009. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-and alpha;. Cell 137:1100-11
33. Cho YS, Challa S, Moquin D, Genga R, Ray TD, et al. 2009. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112-23
34. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, et al. 2009. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325:332-36
35. Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, et al. 2012. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150:339-50
36. Li D, Xu T, Cao Y, Wang H, Li L, et al. 2015. A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis. PNAS 112:5017-22
37. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T. 2010. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci. Signal. 3:re4
38. Upton JW, Kaiser WJ, Mocarski ES. 2008. Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J. Biol. Chem. 283:16966-70
39. Chen W, Wu J, Li L, Zhang Z, Ren J, et al. 2015. Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat. Cell Biol. 17:434-44
40. Seo J, Lee EW, Sung H, Seong D, Dondelinger Y, et al. 2016. CHIP controls necroptosis through ubiquitylation-and lysosome-dependent degradation of RIPK3. Nat. Cell Biol. 18:291-302
41. Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, QuaratoG, et al. 2014. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157:1189-202
42. Orozco S, Yatim N,Werner MR, Tran H, Gunja SY, et al. 2014. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 21:1511-21
43. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8:297-303
44. Kaiser WJ,Daley-BauerLP, ThapaRJ, Mandal P, Berger SB, et al. 2014. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. PNAS 111:7753-58
45. Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J. 2011. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471:373-76
46. Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, et al. 2014. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513:90-94
47. Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, et al. 2014. Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 192:5476-80
48. Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, et al. 2014. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 193:1539-43
49. Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, et al. 2014. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56:481-95
50. Lukens JR, Vogel P, Johnson GR, Kelliher MA, Iwakura Y, et al. 2013. RIP1-driven autoinflammation targets IL-1αindependently of inflammasomes and RIP3. Nature 498:224-27
51. Kang S, Fernandes-Alnemri T, Rogers C, Mayes L, Wang Y, et al. 2015. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun. 6:7515
52. Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, et al. 2015. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun. 6:6282
53. Cullen SP, Kearney CJ, Clancy DM, Martin SJ. 2015. Diverse activators of the NLRP3 inflammasome promote IL-1βsecretion by triggering necrosis. Cell Rep. 11:1535-48
54. Moriwaki K, Bertin J, Gough PJ, Chan FK. 2015. ARIPK3-caspase 8 complex mediates atypical pro-IL-1 βprocessing. J. Immunol. 194:1938-44
55. Brenner D, Blaser H, Mak TW. 2015. Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15:362-74
56. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, et al. 2011. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471:363-67
57. Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, et al. 2012. Survival function of the FADDCASPASE-8-cFLIP(L) complex. Cell Rep. 1:401-7
58. Weinlich R, Oberst A, Dillon CP, Janke LJ, Milasta S, et al. 2013. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep. 5:340-48
59. Ram DR, Ilyukha V, Volkova T, Buzdin A, Tai A, et al. 2016. Balance between short and long isoforms of cFLIP regulates Fas-mediated apoptosis in vivo. PNAS 113:1606-11
60. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, et al. 1998. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9:267-76
61. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, et al. 2011. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368-72
62. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, et al. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. PNAS 93:2131-36
63. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392:296-300
64. Yeh WC, de la Pompa JL, McCurrach ME, Shu HB, Elia AJ, et al. 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279:1954-58
65. YehWC, Itie A, Elia AJ, Ng M, Shu HB, et al. 2000. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12:633-42
66. BonnetMC, Preukschat D, Welz PS, van LooG, Ermolaeva MA, et al. 2011. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35:572-82
67. Welz PS,Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, et al. 2011. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477:330-34
68. Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, et al. 2011. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 477:335-39
69. Schock SN, Young JA, He TH, Sun Y, Winoto A. 2015. Deletion of FADD in macrophages and granulocytes results in RIP3-and MyD88-dependent systemic inflammation. PLOS ONE 10:e0124391
70. Osborn SL, Diehl G, Han SJ, Xue L, Kurd N, et al. 2010. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. PNAS 107:13034-39
71. Ch'en IL, Beisner DR, Degterev A, Lynch C, Yuan J, et al. 2008. Antigen-mediated T cell expansion regulated by parallel pathways of death. PNAS 105:17463-68
72. Lu JV, Weist BM, van Raam BJ, Marro BS, Nguyen LV, et al. 2011. Complementary roles of Fasassociated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. PNAS 108:15312-17
73. Vercammen D, Brouckaert G, Denecker G, Van CraenM, DeclercqW, et al. 1998. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188:919-30
74. McComb S, Cheung HH, Korneluk RG, Wang S, Krishnan L, Sad S. 2012. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ. 19:1791-801
75. FeoktistovaM, Geserick P, Kellert B, Dimitrova DP, Langlais C, et al. 2011. cIAPs block Ripoptosome formation, aRIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43:449-63
76. YabalM,Muller N, Adler H, Knies N, Gross CJ, et al. 2014. XIAP restricts TNF-and RIP3-dependent cell death and inflammasome activation. Cell Rep. 7:1796-808
77. Vanlangenakker N, Vanden Berghe T, Bogaert P, Laukens B, Zobel K, et al. 2011. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ. 18:656-65
78. Moquin DM, McQuade T, Chan FK. 2013. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis. PLOS ONE 8:e76841
79. Hitomi J, Christofferson DE, Ng A, Yao J,Degterev A, et al. 2008. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135:1311-23
80. O'Donnell MA, Perez-Jimenez E, Oberst A, Ng A, Massoumi R, et al. 2011. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat. Cell Biol. 13:1437-42
81. Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, Vanden Berghe T. 2011. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis. 2:e230
82. Rickard JA, Anderton H, EtemadiN,Nachbur U, DardingM, et al. 2014. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. eLife 3:e03464
83. de Almagro MC, Goncharov T, Newton K, Vucic D. 2015. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. Cell Death Dis. 6:e1800
84. Bellail AC,Olson JJ, Yang X, Chen ZJ, HaoC. 2012. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov. 2:140-55
85. PeltzerN,RieserE,Taraborrelli L, Draber P, DardingM, et al. 2014.HOIPdeficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 9:153-65
86. OnizawaM, Oshima S, Schulze-TopphoffU, Oses-Prieto JA, Lu T, et al. 2015. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat. Immunol. 16:618-27
87. Petersen SL, Chen TT, Lawrence DA, Marsters SA, Gonzalvez F, Ashkenazi A. 2015. TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ. 22:1846-57
88. Karl I, Jossberger-Werner M, Schmidt N, Horn S, Goebeler M, et al. 2014. TRAF2 inhibits TRAILand CD95L-induced apoptosis and necroptosis. Cell Death Dis. 5:e1444
89. Lamothe B, Lai Y, Xie M, Schneider MD, Darnay BG. 2013. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol. Cell. Biol. 33:582-95
90. Dondelinger Y, Aguileta MA, Goossens V, Dubuisson C, Grootjans S, et al. 2013. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ. 20:1381-92
91. Morioka S, Broglie P, Omori E, Ikeda Y, Takaesu G, et al. 2014. TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation. J. Cell Biol. 204:607-23
92. Dondelinger Y, Jouan-Lanhouet S, Divert T, Theatre E, Bertin J, et al. 2015. NF-κB-independent role of IKKα/IKKβ in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol. Cell 60:63-76
93. Rebsamen M, Heinz LX, Meylan E, Michallet MC, Schroder K, et al. 2009. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-κB. EMBO Rep. 10:916-22
94. Upton JW, Kaiser WJ,Mocarski ES. 2012. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virusinduced programmed necrosis that is targeted bymurine cytomegalovirus vIRA. CellHostMicrobe 11:290-97
95. Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, et al. 2013. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288:31268-79
96. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-5
97. Zitvogel L, Galluzzi L, Kepp O, Smyth MJ,Kroemer G. 2015. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15:405-14
98. Kaiser WJ, Upton JW, Mocarski ES. 2008. Receptor-interacting protein homotypic interaction motifdependent control of NF-κB activation via the DNA-dependent activator of IFN regulatory factors. J. Immunol. 181:6427-34
99. Gay NJ, Symmons MF, Gangloff M, Bryant CE. 2014. Assembly and localization of Toll-like receptor signalling complexes. Nat. Rev. Immunol. 14:546-58
100. Zou J, Kawai T, Tsuchida T, Kozaki T, Tanaka H, et al. 2013. Poly IC triggers a cathepsin D-and IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis. Immunity 38:717-28
101. Kim SJ,Li J. 2013. Caspase blockade induces RIP3-mediated programmed necrosis inToll-like receptoractivated microglia. Cell Death Dis. 4:e716
102. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. 2012. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13:954-62
103. Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, et al. 2013. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. PNAS 110:3109-18
104. McComb S, Cessford E, Alturki NA, Joseph J, Shutinoski B, et al. 2014. Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. PNAS 111:3206-13
105. vanRaam BJ, Ehrnhoefer DE, Hayden MR, Salvesen GS. 2013. Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6. Cell Death Differ. 20:86-96
106. McComb S, Shutinoski B, Thurston S, Cessford E, Kumar K, Sad S. 2014. Cathepsins limit macrophage necroptosis through cleavage of Rip1 kinase. J. Immunol. 192:5671-78
107. Rajput A, Kovalenko A, Bogdanov K, Yang SH, Kang TB, Kim JC, et al. 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34:340-51
108. Feng S, Yang Y, Mei Y,Ma L, Zhu DE, et al. 2007. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal. 19:2056-67
109. Schotte P, DeclercqW, Van Huffel S, Vandenabeele P, Beyaert R. 1999. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442:117-21
110. Duprez L, Bertrand MJ, Vanden BergheT,Dondelinger Y, FestjensN, Vandenabeele P. 2012. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. J. Biol. Chem. 287:14863-72
111. Chen G, Cheng X, Zhao M, Lin S, Lu J, et al. 2015. RIP1-dependent Bid cleavage mediates TNFα-induced but Caspase-3-independent cell death in L929 fibroblastoma cells. Apoptosis 20:92-109
112. Karch J, Kanisicak O, Brody MJ, Sargent MA,MichaelDM, Molkentin JD. 2015. Necroptosis interfaces with MOMP and the MPTP in mediating cell death. PLOS ONE 10:e0130520
113. Lim SY, Davidson SM, Mocanu MM, Yellon DM, Smith CC. 2007. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovasc. Drugs Ther. 21:467-69
114. Zhang T, Zhang Y, CuiM, Jin L, Wang Y, et al. 2016. CaMKII is a RIP3 substrate mediating ischemiaand oxidative stress-induced myocardial necroptosis. Nat. Med. 22:175-82
115. Linkermann A, Brasen JH, Darding M, Jin MK, Sanz AB, et al. 2013. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. PNAS 110:12024-29
116. Jouan-Lanhouet S, ArshadMI, Piquet-Pellorce C,Martin-Chouly C, LeMoigne-Muller G, et al. 2012. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ. 19:2003-14
117. Sosna J, Voigt S, Mathieu S, Lange A, Thon L, et al. 2014. TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol. Life Sci. 71:331-48
118. Canli O, Alankus YB, Grootjans S, Vegi N, Hultner L, et al. 2016. Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 127:139-48
119. Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, et al. 2014. Synchronized renal tubular cell death involves ferroptosis. PNAS 111:16836-41
120. Newton K, Sun X, Dixit VM. 2004. Kinase RIP3 is dispensable for normal NF-κBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24:1464-69
121. Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, et al. 2014. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513:95-99
122. WongWW,Vince JE, Lalaoui N, Lawlor KE,ChauD, et al. 2014. cIAPs and XIAP regulatemyelopoiesis through cytokine production in an RIPK1-and RIPK3-dependent manner. Blood 123:2562-72
123. Roderick JE, Hermance N, Zelic M, Simmons MJ, Polykratis A, et al. 2014. Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis. PNAS 111:14436-41
124. Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, et al. 2014. RIPK1 regulates RIPK3-MLKLdriven systemic inflammation and emergency hematopoiesis. Cell 157:1175-88
125. Matsuoka Y, Tsujimoto Y. 2015. Role of RIP1 in physiological enterocyte turnover in mouse small intestine via nonapoptotic death. Genes Cells 20:11-28
126. YatimN, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, et al. 2015. RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells. Science 350:328-34
127. Huang Z,Wu SQ, Liang Y, Zhou X, ChenW, et al. 2015. RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17:229-42
128. Wang X, Li Y, Liu S, Yu X, Li L, et al. 2014. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. PNAS 111:15438-43
129. GuoH, Omoto S, HarrisPA, Finger JN,Bertin J, et al. 2015. Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe 17:243-51
130. Upton JW, Kaiser WJ, Mocarski ES. 2010. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7:302-13
131. Omoto S, Guo H, Talekar GR, Roback L, Kaiser WJ, Mocarski ES. 2015. Suppression of RIP3-dependent necroptosis by human cytomegalovirus. J. Biol. Chem. 290:11635-48
132. Weng D, Marty-Roix R, Ganesan S, Proulx MK, Vladimer GI, et al. 2014. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. PNAS 111:7391-96
133. Wang X, JiangW, Yan Y, Gong T, Han J, et al. 2014. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat. Immunol. 15:1126-33
134. Deutsch M, Graffeo CS, Rokosh R, Pansari M, Ochi A, et al. 2015. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis. 6:e1759
135. Bleriot C, Dupuis T, Jouvion G, Eberl G, Disson O, Lecuit M. 2015. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. Immunity 42:145-58
136. Gonzalez-Juarbe N, Gilley RP, Hinojosa CA, Bradley KM, Kamei A, et al. 2015. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLOS Pathog. 11:e1005337
137. Gaiha GD, McKim KJ,Woods M, Pertel T, Rohrbach J, et al. 2014. DysfunctionalHIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosis. Immunity 41:1001-12
138. Pan T,Wu S, He X, Luo H, Zhang Y, et al. 2014. Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes. PLOS ONE 9:e93944
139. Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, et al. 2014. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc. Res 103:206-16
140. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, et al. 2005. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658-62
141. Oerlemans MI, Liu J, Arslan F, den Ouden K, van Middelaar BJ, et al. 2012. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res. Cardiol. 107:270
142. Koudstaal S, Oerlemans MI, Van der Spoel TI, Janssen AW, Hoefer IE, et al. 2015. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs. Eur. J. Clin. Investig. 45:150-59
143. Wang Q, Liu Z, Ren J, Morgan S, Assa C, Liu B. 2015. Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation. Circ. Res. 116:600-11
144. Meng L, JinW,Wang X. 2015. RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality. PNAS 112:11007-12
145. Lin J, Li H, Yang M, Ren J, Huang Z, et al. 2013. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep. 3:200-10
146. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, et al. 2005. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1:112-19
147. Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ. 2011. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J. Cereb. Blood Flow Metab. 31:178-89
148. Chavez-Valdez R, Martin LJ, Flock DL, Northington FJ. 2012. Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 219:192-203
149. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, et al. 2010. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J. Neurosci. Res. 88:1569-76
150. Trichonas G, Murakami Y, Thanos A, Morizane Y, KayamaM, et al. 2010. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. PNAS 107:21695-700
151. Dong K, ZhuH, Song Z, Gong Y,Wang F, et al. 2012. Necrostatin-1 protects photoreceptors from cell death and improves functional outcome after experimental retinal detachment.Am. J. Pathol. 181:1634-41
152. Murakami Y, Matsumoto H, Roh M, Giani A, Kataoka K, et al. 2014. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ. 21:270-77
153. King MD, Whitaker-Lea WA, Campbell JM, Alleyne CH Jr., Dhandapani KM. 2014. Necrostatin-1 reduces neurovascular injury after intracerebral hemorrhage. Int. J. Cell Biol. 2014:495817
154. Su X, Wang H, Kang D, Zhu J, Sun Q, Li T, Ding K. 2015. Necrostatin-1 ameliorates intracerebral hemorrhage-induced brain injury in mice through inhibiting RIP1/RIP3 pathway. Neurochem. Res. 40:643-50
155. You Z, Savitz SI, Yang J, Degterev A, Yuan J, et al. 2008. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J. Cereb. Blood Flow Metab. 28:1564-73
156. Wang Y, Wang H, Tao Y,Zhang S, Wang J, Feng X. 2014. Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury. Neuroscience 266:91-101
157. Liu M, Wu W, Li H, Li S, Huang LT, et al. 2015. Necroptosis, a novel type of programmed cell death, contributes to early neural cells damage after spinal cord injury in adult mice. J. Spinal Cord Med. 38:745-53
158. Fan H, Tang HB, Kang J, Shan L, Song H, et al. 2015. Involvement of endoplasmic reticulum stress in the necroptosis of microglia/macrophages after spinal cord injury. Neuroscience 311:362-73
159. Fan H, Zhang K, Shan L, Kuang F, Chen K, et al. 2016. Reactive astrocytes undergo M1 microglia/ macrophages-induced necroptosis in spinal cord injury. Mol. Neurodegener. 11:14
160. Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, et al. 2014. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81:1001-8
161. Zheng HW, Chen J, Sha SH. 2014. Receptor-interacting protein kinases modulate noise-induced sensory hair cell death. Cell Death Dis. 5:e1262
162. Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, et al. 2012. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int. 81:751-61
163. Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, et al. 2016. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat. Commun. 7:10274
164. Tristao VR, Goncalves PF,DalboniMA, BatistaMC, DuraoMde S Jr.,Monte JC. 2012. Nec-1 protects against nonapoptotic cell death in cisplatin-induced kidney injury. Ren. Fail. 34:373-77
165. Linkermann A, Heller JO, Prokai A, Weinberg JM, De Zen F, et al. 2013. The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI inmice. J. Am. Soc.Nephrol. 24:1545-57
166. Xu Y, Ma H, Shao J,Wu J, Zhou L, et al. 2015. A role for tubular necroptosis in cisplatin-induced AKI. J. Am. Soc. Nephrol. 26:2647-58
167. Tristao VR, Pessoa EA, Nakamichi R, Reis LA, Batista MC, et al. 2016. Synergistic effect of apoptosis and necroptosis inhibitors in cisplatin-induced nephrotoxicity. Apoptosis 21:51-59
168. Zhu Y, Cui H, GanH, Xia Y, Wang L, et al. 2015. Necroptosis mediated by receptor interaction protein kinase 1 and 3 aggravates chronic kidney injury of subtotal nephrectomised rats. Biochem. Biophys. Res. Commun. 461:575-81
169. Rosentreter D, Funken D, Reifart J, Mende K, Rentsch M, Khandoga A. 2015. RIP1-dependent programmed necrosis is negatively regulated by caspases during hepatic ischemia-reperfusion. Shock 44:72-76
170. Ramachandran A, McGill MR,Xie Y, NiHM,DingWX, Jaeschke H. 2013. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58:2099-108
171. Li JX, Feng JM, Wang Y, Li XH, Chen XX, et al. 2014. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis. 5:e1278
172. Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE. 2013. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57:1773-83
173. Wang S, Ni HM, Dorko K, Kumer SC, Schmitt TM, et al. 2016. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury. Oncotarget 7:17681-98
174. Gautheron J, Vucur M, Reisinger F, Cardenas DV, Roderburg C, et al. 2014. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol. Med. 6:1062-74
175. Afonso MB, Rodrigues PM, Carvalho T, Caridade M, Borralho P, et al. 2015. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin. Sci. 129:721-39
176. Dara L, Johnson H, Suda J, Win S, Gaarde W, et al. 2015. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology 62:1847-57
177. Linkermann A, Stockwell BR, Krautwald S, Anders HJ. 2014. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat. Rev. Immunol. 14:759-67
178. Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, et al. 2015. Activation of necroptosis in multiple sclerosis. Cell Rep. 10:1836-49
179. Duprez L, TakahashiN, Van Hauwermeiren F, Vandendriessche B, Goossens V, et al. 2011. RIP kinasedependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35:908-18
180. Huang Z, Epperly M, Watkins SC, Greenberger JS, Kagan VE, Bayir H. 2016. Necrostatin-1 rescues mice from lethal irradiation. Biochim. Biophys. Acta 1862:850-56
181. Saito N, Qiao H, Yanagi T, Shinkuma S, Nishimura K, et al. 2014. An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci. Transl. Med. 6:245ra95
182. Pavlosky A, Lau A, Su Y, Lian D, Huang X, et al. 2014. RIPK3-mediated necroptosis regulates cardiac allograft rejection. Am. J. Transplant. 14:1778-90
183. Lau A,Wang S, Jiang J, Haig A, Pavlosky A, et al. 2013. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am. J. Transplant. 13:2805-18
184. Zhao H, Ning J, Lemaire A, Koumpa FS, Sun JJ, et al. 2015. Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. Kidney Int. 87:738-48
185. Mizumura K, Cloonan SM, Nakahira K, Bhashyam AR, Cervo M, et al. 2014. Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J. Clin. Investig. 124:3987-4003
186. Pouwels SD, Zijlstra GJ, van der Toorn M, Hesse L, Gras R, et al. 2016. Cigarette smoke-induced necroptosis and DAMP release trigger neutrophilic airway inflammation in mice. Am. J. Physiol. Lung. Cell Mol. Physiol. 310:L377-86
187. Fan H, Liu F, Dong G, Ren D, Xu Y, et al. 2014. Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus. Cell Death Dis. 5:e1416
188. Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, et al. 2016. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology 5:e1149673
189. Werthmoller N, Frey B, Wunderlich R, Fietkau R, Gaipl US. 2015. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide-and T-cell-dependent manner. Cell Death Dis. 6:e1761
190. Koks CA, Garg AD, Ehrhardt M, Riva M, Vandenberk L, et al. 2015. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death. Int. J. Cancer 136:E313-325
191. Takemura R, Takaki H, Okada S, Shime H, Akazawa T, et al. 2015. PolyI:C-induced, TLR3/RIP3-dependent necroptosis backs up immune effector-mediated tumor elimination in vivo. Cancer Immunol. Res. 3:902-14
192. Liu ZY, Wu B, Guo YS, Zhou YH, Fu ZG, et al. 2015. Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice. Am. J. Cancer Res. 5:3174-85
193. Feng X, Song Q, Yu A, Tang H, Peng Z, Wang X. 2015. Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer. Neoplasma 62:592-601
194. Moriwaki K, Bertin J, Gough PJ, Orlowski GM, Chan FK. 2015. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death. Cell Death Dis. 6:e1636
195. Nugues AL, El Bouazzati H, Hetuin D, Berthon C, Loyens A, et al. 2014. RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death Dis. 5:e1384
196. Koo GB, Morgan MJ, Lee DG, Kim WJ, Yoon JH, et al. 2015. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 25:707-25
197. Ruan J, Mei L, Zhu Q, Shi G, Wang H. 2015. Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer. Int. J. Clin. Exp. Pathol. 8:15035-38
198. He L, Peng K, Liu Y, Xiong J, Zhu FF. 2013. Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients. OncoTargets Ther. 6:1539-43
199. Fauster A, Rebsamen M, Huber KV, Bigenzahn JW, Stukalov A, et al. 2015. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. Cell Death Dis. 6:e1767